Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
about
Inhibitory effect of soluble platelet-derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice.Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors.Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides.Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability
P2860
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
@ast
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
@en
type
label
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
@ast
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
@en
prefLabel
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
@ast
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
@en
P2093
P2860
P356
P1476
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells
@en
P2093
Lothar Kanz
Peter Brossart
Stefan Balabanov
Tim H Brümmendorf
P2860
P304
P356
10.1196/ANNALS.1349.022
P407
P50
P577
2005-06-01T00:00:00Z